Supplementary Table 2 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression
2025 · 0 citations
https://doi.org/10.1158/2767-9764.28727377
I
Isabella O’Reilly
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
27
Papers
1
Citations
1
h-index
0
i10-index
Isabella O’Reilly is an academic researcher from Baylor College of Medicine. The author has contributed to research in topics: Cell Adhesion Molecules Research & Chemokine receptors and signaling & Immunotherapy and Immune Responses. The author has an h-index of 1, co-authored 23 publications.
Papers by this author
worksSupplementary Data from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression
2025 · 0 citations
https://doi.org/10.1158/2767-9764.28727395
Supplementary Figure 3 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression
2025 · 0 citations
https://doi.org/10.1158/2767-9764.28727386
Supplementary Figure 2 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression
2025 · 0 citations
https://doi.org/10.1158/2767-9764.28727389
Supplementary Figure 1. from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression
2025 · 0 citations
https://doi.org/10.1158/2767-9764.28727392
Supplementary Table 1 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression
2025 · 0 citations
https://doi.org/10.1158/2767-9764.28727383
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat